Genetic study of severe preeclampsia in pregnancy
Part of Women’s health & pregnancy clinical trials.
This study looks for genes that may be linked to severe preeclampsia, a serious blood pressure condition in pregnancy. It compares women with severe preeclampsia to those with healthy pregnancies to understand why it happens.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old and pregnant between 24 and 41 weeks
- You have been diagnosed with severe preeclampsia (high blood pressure plus other severe signs)
- You and your child's other parent agree to provide placenta, cord blood, and newborn data
- You do not have pre-pregnancy diabetes, a multiple pregnancy, or a history of certain medical conditions
- You do not smoke, drink alcohol, or use drugs during pregnancy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
This study looks at what causes preeclampsia, a condition with high blood pressure and protein in the urine during pregnancy. It may help researchers understand why some women get it, so they can find better ways to prevent or treat it.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This study looks at how certain hormone receptors might be linked to preeclampsia, a pregnancy complication involving high blood pressure. It aims to understand why some women get preeclampsia and could help improve care in the future.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This study tests a tool (called fullPIERS) that uses common lab tests and vital signs to predict if a pregnant person with preeclampsia might have serious complications. It helps doctors identify who needs closer monitoring.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.